The results suggest that NSE is a semi strong form efficient market. Also, the abnormal returns before earnings announcement and after it are not significantly different from each other. Furthermore, AR (1) process was used to estimate the speed of information adjustment at NSE. It was found ...
3. Analysis of Consolidated Financial Condition, Results of Operations, and Cash Flows (1) Analysis of Results of Operations For the three months ended March 31, 2017, revenues of the Company decreased by ¥2.5 billion (0.6%) from the corresponding period in the prior year to ¥402.8 ...
Results 11.0*1 26.9*2 YoY +15.8 Temporary Expenses 2.2 4.6 +2.3 *1 Gains related to sales of subsidiary of Daiichi Sankyo (China) (6.0) Gains on reversal related to closure of Plexxikon (3.3) *2 Lump sum payment received from Novartis following the settlement of Plexxikon's patent ...
3. Analysis of Consolidated Financial Condition, Results of Operations, and Cash Flows (1) Analysis of Results of Operations For the six months ended June 30, 2017, revenues of the Company increased by ¥49.9 billion (6.3%) from the corresponding period in the prior year to ¥846.0 ...
3. Analysis of Consolidated Financial Condition, Results of Operations, and Cash Flows (1) Analysis of Results of Operations For the six months ended June 30, 2017, revenues of the Company increased by ¥49.9 billion (6.3%) from the corresponding period in the prior year to ¥846.0 ...